Cardiovascular Disease Doctors in Mount Arlington, NJ Accepting Medicare

4 Cardiovascular Disease doctors found. Showing 1 - 4

Rhuna Shen, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Valley Rd, Suite 102, Mount Arlington, NJ 07856 Phone: 973-770-7899

Austin Ferrier, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Valley Rd, Suite 102, Mount Arlington, NJ 07856 Phone: 973-770-7899    Fax: 973-770-7840

Barry Hunt Lowell, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Valley Rd, Suite 102, Mount Arlington, NJ 07856 Phone: 973-770-7899

Dean Michael Barton, Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 400 Valley Rd, Suite 102, Mount Arlington, NJ 07856 Phone: 973-770-7899    Fax: 973-770-7840

News Archive

Researchers receive NIH grant to identify potential links between cancer risk and automobile traffic

A professor from the University of Miami School of Business Administration, along with collaborators from the Yale School of Public Health, has received a $453,000 grant from the National Cancer Institute of the National Institutes of Health to identify potential links between cancer risk and the proximity of homes to heavy automobile traffic.

Montana State University offers new biomedical technologies for prevention, treatment of viral infections

Researchers at Montana State University have developed six new biomedical technologies that could have applications for treating antibiotic resistant infections, fungal infections and viral infections; boosting humans' innate immunity and improving scientists' ability to study such compounds. The technologies are available for licensing to interested companies and entrepreneurs.

Anacor Pharmaceuticals enrolls first patient in AN2728 Phase 3 trial for treatment of atopic dermatitis

Anacor Pharmaceuticals announced today that the first patient has been enrolled in the Phase 3 trial of AN2728, a novel boron-based phosphodiesterase-4 (PDE-4) inhibitor, for the topical treatment of mild-to-moderate atopic dermatitis. Atopic dermatitis is a chronic rash characterized by inflammation and itch and affects approximately 10% - 20% of infants and young children.

WHO recommends worldwide use of rotavirus vaccine for children

To reduce an estimated half million deaths and two million hospitalizations from diarrhea caused by rotavirus each year, the WHO on Friday recommended that oral rotavirus vaccines be added to national childhood immunization programs, broadening access to the vaccine in the developing world, Reuters reports.

Study provides deeper understanding into genetic basis of neuropsychiatric disorders

A study by scientists at the Children's Medical Center Research Institute at UT Southwestern is providing insight into the genetic basis of neuropsychiatric disorders.

Read more Medical News

› Verified 9 days ago